Page last updated: 2024-10-28

hydroxychloroquine and Neuroendocrine Tumors

hydroxychloroquine has been researched along with Neuroendocrine Tumors in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research Excerpts

ExcerptRelevanceReference
"Axitinib (AXI) is a tyrosine kinase inhibitor, currently under investigation in an international phase II/III trial including thymic neuroendocrine tumors."1.56SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view. ( Fazio, N; Funicelli, L; Garcia-Carbonero, R; Gervaso, L; Laffi, A; Pellicori, S; Rubino, M; Spada, F; Zampino, G, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Lin, S1
Han, C1
Lou, X1
Wu, ZB1
Spada, F1
Pellicori, S1
Zampino, G1
Funicelli, L1
Gervaso, L1
Laffi, A1
Rubino, M1
Garcia-Carbonero, R1
Fazio, N1

Other Studies

2 other studies available for hydroxychloroquine and Neuroendocrine Tumors

ArticleYear
Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Adult; Cabergoline; Ergolines; Humans; Hydroxychloroquine; Lactotrophs; Male; Neuroendocrine Tumors;

2022
SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view.
    Endocrine, 2020, Volume: 70, Issue:1

    Topics: Aged; Axitinib; Azithromycin; Betacoronavirus; Carcinoid Tumor; Comorbidity; Coronavirus Infections;

2020